News

SWOG Front Line banner
The Front Line
Nov 4, 2022

Because You Asked: Research Results

Stratification factors can reduce statistical power
Press Release
Nov 3, 2022

Stratification Can Reduce Statistical Power

Adding stratification factors can reduce a small trial’s statistical power
SWOG Front Line banner
The Front Line
Oct 28, 2022

A Chicago Meeting to Remember

S/N1806 toxicity data reveal no safety concerns
Press Release
Oct 25, 2022

S/N1806 Toxicity Data: No Safety Concerns

RxPONDER Radiotherapy Analysis at ASTRO 2022
Press Release
Oct 24, 2022

Radiotherapy and Recurrence in RxPONDER Trial

SWOG Front Line banner
The Front Line
Sep 30, 2022

Lyman Stepping Down as EO; Sun Stepping Up

SWOG Front Line banner
The Front Line
Sep 23, 2022

A Call for Candidates

The SWOG group chair nominating process is underway.
SWOG Front Line banner
The Front Line
Sep 16, 2022

The Word of the Day is "Neoadjuvant"

S1801 Melanoma Results at ESMO 2022
Press Release
Sep 11, 2022

Neoadjuvant IO Boosts High-Risk Melanoma EFS

SWOG researchers have found that starting pembrolizumab before surgery instead of waiting until after surgery significantly improves the outlook for patients with stage III-IV melanoma.